Home›Companies›Biotech & Pharma›Renovion

Renovion, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 28, 2023·Suggest an edit

About Renovion

Renovion is a private company based in Chapel Hill, North Carolina. It has reported $25,828,436 raised in five offerings on Form D since August 2016. Its chief executive is Daniel Copeland.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 22, 2022Mar 28, 2023$15,017,305of $15.0M target24$625KEquityRule 506(b)Form D ↗
Feb 14, 2020Feb 27, 2020amended May 29, 2020$8,099,999fully sold43$188KEquityRule 506(b)Form D/A ↗1 earlier filing
Jan 25, 2019Feb 7, 2019$492,196of $800K target10$49,220EquityRule 506(b)Form D ↗
May 2, 2018May 15, 2018$350,000fully sold12$29,167EquityRule 506(b)Form D ↗
Aug 11, 2016Aug 30, 2016amended Jan 17, 2017$1,868,936of $2.0M target13$143KEquityRule 506(b)Form D/A ↗2 earlier filings
Total, five offerings$25,828,436

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Renovion's Form D filed Mar 28, 2023.

TB
DW
DC
Daniel Copeland
Chief Executive Officer and director
JC

Earlier filings also listed Robert Ryan (director, last listed Feb 2019), R. McCoy, Jr. (director, last listed Feb 2019) and Joseph Davis (director, last listed Jan 2017).

Sources

  1. SECRENOVION, INC. Form D, filed Feb 27, 2020
  2. SECRENOVION, INC. Form D/A, filed Aug 30, 2016
  3. SECRENOVION, INC. Form D, filed Aug 30, 2016
  4. SECRENOVION, INC. filing history